Loading resource…

Department of Internal Medicine, College of Health Sciences, Makerere University
The document presents a case of an African-American male living with HIV who experienced hyperglycemia after switching from Efavirenz to dolutegravir. It details the patient's medical history, including chronic kidney disease, diabetes mellitus, and other conditions. The report also explores the potential mechanisms by which integrase strand transfer inhibitors may affect insulin signaling and contribute to diabetes mellitus.
No account needed